期刊
CLINICS IN LIVER DISEASE
卷 21, 期 4, 页码 793-813出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2017.06.006
关键词
Liver transplantation; Immunosuppression; Outcomes; Prophylaxis; Screening
资金
- Novartis
- Abbvie
The focus in liver transplantation in the next 10 years will likely change from preventing viral disease recurrence to minimizing the toll of rejection and fatty liver disease, minimizing the complications from immunosuppression with withdrawal strategies, and more optimal management of long-term risks, such as malignancy, cardiovascular disease, and renal failure. In addition, now that short-term results (< 1 year) have improved significantly, there will be a shift toward improving long-term patient and graft survival, as well as a focus on primary care preventive strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据